January 9, 2023
Israeli drugmaker Teva Pharmaceutical Industries Ltd said there was sufficient participation from U.S. states and local authorities to move forward with its nationwide settlement agreement to resolve opioid-related claims and litigation. Teva said on Monday it has either already settled …
September 19, 2022
Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while confirming he was unlikely to renew his contract next year. After years of …
August 18, 2022
A lawsuit against makers of Zantac was dropped this week just ahead of trial, people familiar with the matter said, after a series of settlements with some of the drugmakers involved. Generic drugmakers Teva Pharmaceutical Industries Ltd., Perrigo Co., Sun …
May 3, 2022
Teva Pharmaceutical Industries believes it would have to pay around $2.6 billion in cash and medicine to settle thousands of lawsuits alleging it and other drug companies fueled the U.S. opioid epidemic. On the heels of two more state settlements …
February 7, 2022
Teva Pharmaceutical Industries Ltd has reached a settlement worth $225 million to resolve claims the drugmaker fueled an opioid epidemic in Texas by improperly marketing addictive pain medications, the state’s attorney general said on Monday. Texas Attorney General Ken Paxton …
January 19, 2022
Teva Pharmaceutical Industries Ltd. has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs. The settlement was disclosed on Tuesday in papers filed in federal court …
August 9, 2021
A lawsuit filed by the state of West Virginia accusing several drug manufacturers of misrepresenting the risks of their painkilling drugs will go to trial next April, Attorney General Patrick Morrisey said Thursday. The Mass Litigation Panel, a group of …
May 13, 2019
U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc. of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by more than 1,000% – and stifle competition for generic drugs, state prosecutors said …
April 24, 2019
Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens, the first claims in what some lawyers expect to be a wave of litigation. Millions of Americans have taken …
October 31, 2018
Kentucky Attorney General Andy Beshear has sued a pharmaceutical company, accusing it of contributing to the state’s opioid epidemic. Beshear says he has sued Pennsylvania-based Teva for marketing its products to treat chronic pain despite the drugs being approved for …